Generate Biomedicines
GENB
9.54
-0.83
-8.00%
Generate Biomedicines
US · GENB
#2875 by market cap
Listed 2026
9.54
-0.83
-8.00%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:32
About Generate Biomedicines
Generate Biomedicines, Inc. is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company was founded in 2018, and is headquartered in Somerville, MA.
- Founded
- 2018
- CEO
- Mr. Michael Nally
- Employees
- 312
- Headquarters
- Somerville, Massachusetts, United States of America
- Fiscal year end
- 12-31
- Website
- generatebiomedicines.com
Company profile
- Exchange
- US
- Symbol
- GENB
- Market-cap rank
- #2875
- Listing date
- 2026-02-27
- Market cap
- 1.23B
- Float cap
- 576.68M
- Shares out
- 129.10M
- Float shares
- 60.45M
Sectors & themes
Quote time 2026-11-20 19:32:29 · For reference only, not investment advice and not tailored to your situation.
Generate Biomedicines discussion 0 comments